Our Global Capital Confidence Barometer shows life sciences expectations continue to be positive, with 50% of executives planning to pursue M&A in the next year.
Life sciences M&A optimism resulted in record deal announcements first quarter
EY Life Sciences Report: Asia-Pacific | Japan | India
Choose your deal strategy wisely
2018 M&A Firepower Report: Life sciences deals and data
Life sciences deal intentions remain above trend
Creating a framework for future medtech innovation
How the genius of technology is transforming health care
Oncology R&D driving strategic transformation
Life Sciences Industry
Life Sciences Consulting Services
Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for healthcare — one driven by patients and focused on health outcomes.
Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in Advisory, Assurance, Tax and Transactions.
Partner & National Leader - Life Sciences
+91 (22) 61920620
+91 (22) 61921206
Connect with us
Stay connected with us through social media, email alerts or webcasts.
Get ready to reinvent pharma sales & marketing through digital in India